Clorox (NYSE: CLX) insider transactions
In the twelve months to 10 November 2026, executives and directors of Clorox reported 0 open-market sales and 3 open-market purchases of 13,000 shares ($1.2m), by 1 person, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 4 November 2026 | Breber Pierre R | Director | Open-market purchase | +4,000 | $100.06 | 22,000 | Form 4 |
| 5 October 2026 | Barton Nina | EVP-Chief Growth & Strategy Of | Shares withheld for tax | −1,106 | $80.41 | 36,179 | Form 4 |
| 5 October 2026 | Bellet Luc | EVP - Chief Financial Officer | Grant or award | +1,677 | $80.41 | 76,471 | Form 4 |
| 5 October 2026 | Bellet Luc | EVP - Chief Financial Officer | Shares withheld for tax | −580 | $80.41 | 75,891 | Form 4 |
| 5 October 2026 | Bellet Luc | EVP - Chief Financial Officer | Shares withheld for tax | −1,031 | $80.41 | 74,860 | Form 4 |
| 5 October 2026 | Hilt Angela C | EVP - Chief Legal Officer | Grant or award | +6,637 | $80.41 | 74,414 | Form 4 |
| 5 October 2026 | Hilt Angela C | EVP - Chief Legal Officer | Shares withheld for tax | −2,296 | $80.41 | 72,118 | Form 4 |
| 5 October 2026 | Hilt Angela C | EVP - Chief Legal Officer | Shares withheld for tax | −2,351 | $80.41 | 69,767 | Form 4 |
| 5 October 2026 | Hyder Chris T | EVP-Chief Operating Officer | Grant or award | +4,191 | $80.41 | 94,618 | Form 4 |
| 5 October 2026 | Hyder Chris T | EVP-Chief Operating Officer | Shares withheld for tax | −100 | $80.41 | 94,518 | Form 4 |
| 5 October 2026 | Hyder Chris T | EVP-Chief Operating Officer | Shares withheld for tax | −1,532 | $80.41 | 92,986 | Form 4 |
| 5 October 2026 | Marriner Kirsten | EVP - Chief Admin Officer | Grant or award | +6,637 | $80.41 | 83,591 | Form 4 |
| 5 October 2026 | Marriner Kirsten | EVP - Chief Admin Officer | Shares withheld for tax | −1,951 | $80.41 | 81,640 | Form 4 |
| 5 October 2026 | Marriner Kirsten | EVP - Chief Admin Officer | Shares withheld for tax | −2,142 | $80.41 | 79,498 | Form 4 |
| 5 October 2026 | Peck Laurene E | VP - CAO & Corp Controller | Grant or award | +1,172 | $80.41 | 10,386 | Form 4 |
| 5 October 2026 | Peck Laurene E | VP - CAO & Corp Controller | Shares withheld for tax | −30 | $80.41 | 10,356 | Form 4 |
| 5 October 2026 | Peck Laurene E | VP - CAO & Corp Controller | Shares withheld for tax | −339 | $80.41 | 10,017 | Form 4 |
| 5 October 2026 | Rendle Linda J | Chief Executive Officer | Grant or award | +29,352 | $80.41 | 282,488 | Form 4 |
| 5 October 2026 | Rendle Linda J | Chief Executive Officer | Shares withheld for tax | −692 | $80.41 | 281,796 | Form 4 |
| 5 October 2026 | Rendle Linda J | Chief Executive Officer | Shares withheld for tax | −11,989 | $80.41 | 269,807 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Clorox page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.